2nd Annual Obesity & Cardiometabolic Innovation Forum

CONNECTING OBESITY, DIABETES & CARDIOMETABOLIC BREAKTHROUGHS

5th of June 2026|ROYAL SONESTA NEW ORLEANS | USA

Investors:

501 Ventures, LLC

82VS

Advent Capital Management, LLC

AFK & Partners Asset Management LLC

age1 Capital Management, LLC

Ally Bridge Group

ALSA Ventures

Andera Partners SA

Arkin Capital

Balyasny Asset Management L.P.

Breslin AG

Candlewood Management

Eight Bridges

Elliott Management Corporation

Expert Systems, Inc

Forty51 Ventures AG

Generation Fund Life Sciences Fund I

GL Capital Group

HBM Partners AG

Health Innovation Capital

Hevolution

Hummingbird Ventures

Invus SAS

Lifespan Vision Ventures LLC

Novo Nordisk A/S

Oppenheimer & Co. Inc.

Prevail Partners LLC

PriveBio, Inc.

Privos Capital

RiverVest Partner

RTW Investments, LLC

SaniMed Science Group

Seventure Partners

Shanda Grab Ventures Limited

Stifel

Tailwinds Vc

TransPacific Venture Capital Partners

V-Bio Ventures BV

Versant Ventures

Last updated: June 8, 2026

SACHS ASSOCIATES SWITZERLAND AG

Aeschenvorstadt 4
Basel | CH-4051
Switzerland

SACHS ASSOCIATES LTD.

3rd floor, 89-90 Paul Street
London | EC2A 4NE
United Kingdom
Privacy Policy

© COPYRIGHT 2026. ALL RIGHTS RESERVED.